CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,073 enrolled
Drug / intervention
SMARTHealth Diabetesbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02726100
NCT02726100N/ACompleted
CompareCT.gov

Systematic Medical Assessment, Referral and Treatment for Diabetes Care in China Using Lay Family Health Promoters

The George Institute for Global Health, China·interventional·Posted Apr 1, 2016·Updated Mar 12, 2021

In Brief

A clinical study evaluating SMARTHealth Diabetes for Diabetes Mellitus, Type 2 and 2 related conditions. Completed, enrolled 2,073 participants across 2 sites.

Detailed Summary

It's a community-based parallel-arm cluster Randomized Controlled Trial (RCT). An interactive mobile health management system will be developed to support lay family health promoters and healthcare staff to improve clinical outcomes for family members with Type 2 Diabetes Mellitus (T2DM). 2,000 participants from 80 sites will be chosen from urban (40 communities) and rural (40 villages) settings in Shijiazhuang City, Hebei Province.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2, Hypertension, Dyslipidemias
CountriesChina
CollaboratorsGlobal Alliance for Chronic Diseases (GACD), National Health and Medical Research Council, Australia

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 1, 2016
Enrollment StartAug 1, 2017
Primary CompletionOct 19, 2019
Study CompletionFeb 28, 2021
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 10.3 years ago

Interventions

SMARTHealth Diabetesbehavioral

SMARTHealth Diabetes is an interactive mobile health platform to promote improved self-management for people with T2DM.